🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Heart attacks are most commonly caused by rupture of fatty deposits (plaque...
Status
Completed
Location
Edinburgh Heart Centre
Start Date
2015-03
Trial ID
NCT02110303
Treatments Being Tested
This is a single-centred, double blind randomized controlled trial comparin...
Status
Unknown
Location
Papworth Hospital NHS Foundation Trust
Start Date
2017-01-30
Trial ID
NCT03145194
Treatments Being Tested
The study aims to optimize the dual antiplatelet therapy regimen for patien...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06756945
The purpose of this study is to compare the effects of ticagrelor and clopi...
Status
Completed
Location
Research Site
Start Date
2012-12-04
Trial ID
NCT01732822
Treatments Being Tested
The primary objective of this study is to assess the pharmacodynamic (PD) e...
Status
Completed
Location
Biotrial Inc
Start Date
2018-01-24
Trial ID
NCT03430661
Treatments Being Tested
Percutaneous coronary intervention(PCI) has become the first choice for STE...
Status
Unknown
Location
Cardiology Department, Chinese Armed Police Force Genral Hospital, Beijing China
Start Date
2014-12-12
Trial ID
NCT02913469
Treatments Being Tested
Background: Coronary heart disease is the most common cause of death in ind...
Status
Completed
Location
Medical University of Vienna
Start Date
2010-10
Trial ID
NCT02120092
Treatments Being Tested
The ELECTRA-SIRIO 2 study is a randomized, multicenter, double-blind, inves...
Status
Unknown
Location
Antoni Jurasz University Hospital No. 1
Start Date
2022-02-07
Trial ID
NCT04718025
Treatments Being Tested
The purpose of this study is to compare the effect of ticagrelor versus pla...
Status
Completed
Location
Research Site
Start Date
2014-02-10
Trial ID
NCT01991795
Treatments Being Tested
This will be a dose block-randomized, double-blind, active and placebo cont...
Status
Completed
Location
Seoul National University Hospital
Start Date
2012-03
Trial ID
NCT01526577
Treatments Being Tested